retatrutide latest clinical trial results from a new of (LY3437943; Eli Lilly) found that participants had considerable decreases in body weight at week 48, although this depended on the dose and varied due to Triple hormone receptor agonist retatrutide

This is one of the first longer-term studies into the safety of Ozempic and similar drugs

Directions and Dosage Adults (18+ years): 1 capsule daily

Ohio to end GLP-1 drug weight loss coverage for state workers COLUMBUS, Ohio (WSYX) The Ohio Department of Administrative Services announced that coverage for GLP-1 drugs for weight loss, including Ozempic and Mounjaro, will end for state employees on July 1, 2025

Stomach paralysis or gastroparesis is a functional disorder that affects the stomach muscles, causing them to become paralyzed or weakened

Instead of a large plate of white rice, try a moderate portion of rice with lean protein and vegetables

Science has proved the benefits glutathione provides